Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease.

Eye and brain·2026
Same author

Risk of Stroke Recurrence Following Isolated Retinal Artery Occlusion Versus Minor Stroke or Transient Ischemic Attack.

Stroke·2025
Same author

Opinion article: Neurosurgical treatment for neuro-ophthalmologic conditions.

Frontiers in ophthalmology·2024
Same author

Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

Multiple sclerosis and related disorders·2023
Same author

Optic Nerve Enhancement in the Setting of Wernicke Encephalopathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2023
Same author

Pole to pole.

Survey of ophthalmology·2023

Related Experiment Video

Updated: Jun 10, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Giant cell arteritis.

Julie Falardeau1

  • 1Casey Eye Institute, Oregon Health and Science University, 3303 South West Bond Avenue, Portland, OR 97239, USA. falardea@ohsu.edu

Neurologic Clinics
|July 20, 2010
PubMed
Summary

Giant cell arteritis is a medical emergency requiring prompt diagnosis and treatment to prevent permanent vision loss. Corticosteroids remain the primary treatment for this systemic vasculitis.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Neurology

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis with diverse clinical presentations.
  • It poses a significant risk of profound and irreversible visual loss.
  • GCA is considered a medical emergency due to potential complications.

Purpose of the Study:

  • To emphasize the critical need for prompt diagnosis and treatment of GCA.
  • To highlight the importance of early intervention in preventing visual and neurologic deficits.
  • To underscore the role of specific diagnostic and therapeutic modalities.

Main Methods:

  • Clinical assessment for suspected GCA.
  • Performance of temporal artery biopsy for diagnostic confirmation.
  • Initiation of corticosteroid therapy as the primary treatment.

More Related Videos

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Related Experiment Videos

Last Updated: Jun 10, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Main Results:

  • Prompt diagnosis and treatment are crucial for mitigating severe outcomes.
  • Temporal artery biopsy is a key diagnostic tool.
  • Corticosteroids are the established mainstay of GCA management.

Conclusions:

  • Early recognition and management of GCA are imperative.
  • Aggressive treatment is necessary to prevent devastating complications like blindness.
  • Corticosteroid therapy remains the cornerstone of GCA treatment.